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Abstract 
Introduction: Management of pyogenic spinal infections (PSI) after the development of neurological deficit has not been specifically addressed 
in the literature. We aimed to describe real-life clinical outcomes of PSI in patients admitted to an intensive care unit with neurological deficit 
and identify factors associated with good prognosis. 
Methodology: Consecutive patients admitted to ICU with a possible diagnosis of spinal infection over five years’ period were included. 
Descriptive statistics were performed to examine the demographics and clinical parameters.  
Results: The majority (71%) of patients were male. The mean age was 57.4 years (27-79), and 71% were > 50 years old. At least one underlying 
risk factor was identified in 68% of the patients; the most common comorbidity was diabetes mellitus (DM). All patients have presented with 
fever accompanied by a neurological deficit (86%) and back pain (79%). A complete recovery was achieved in 25% of patients. However, the 
majority of patients had adverse outcomes with 21.4% mortality, and 43% remaining neurological sequelae. Increased age with a cut-off of 65 
years and pre-existing DM were identified as being associated with poor outcome. 
Conclusion: Mortality among patients admitted to ICU with PSI was significantly higher than reported in the literature. The residual 
neurological deficit was common, one-third of patients had remaining neurological sequelae, and only one-fourth had complete recovery. 
Increased age and background DM were the most important determinants of poor clinical outcome. The impact of DM appears to be much 
more important than currently recognised in this population.  
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Introduction 
Pyogenic spinal infections (PSI) compromises a 
wide range of clinical entities, including vertebral 
osteomyelitis, spondylodiscitis, epidural infections, and 
myelitis-spinal cord abscess [1]. Over the last 30 years, 
the prevalence of spinal infections have increased as a 
result of increasing life expectancy and other comorbid 
factors including diabetes, underlying liver and renal 
disease as well as increased use of immunosuppression, 
spinal instrumentation, and advanced imaging 
techniques [2-4]. Although mortality associated with 
PSI has dropped due to the broad use of highly 
bioavailable antimicrobials, there are still significant 
adverse outcomes associated with PSI. Approximately 
one-third of patients develop long-term neurological 
sequela and chronic back pain leading to long-term 
disability [5-7].  
Despite the advances in understanding the 
pathophysiology and microbiology of PSI, early 
diagnosis remains challenging due to the insidious 
onset and non-specific symptoms [8-10,4]. In addition, 
the current management and treatment strategy is 
primarily based on expert opinion informed by limited 
studies [11,12]. Therefore, the optimum management 
strategy including appropriate duration of antimicrobial 
treatment, choice of antimicrobials and the role of 
surgical intervention remains controversial [13]. 
Management of PSI after the development of 
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neurological deficit has not been specifically addressed 
in the literature. In this study, we aimed to describe real-
life clinical outcomes of PSI in patients admitted to an 
intensive care unit with neurological deficit and identify 
factors associated with good prognosis.  
 
Methodology 
Study design and population 
A retrospective cross-sectional study was 
conducted between 1st January 2011 and 31st December 
2015. During this period, consecutive patients (over the 
age of 18) admitted to the intensive care unit (ICU) at 
the Clinical Centre of Serbia with a possible diagnosis 
of spinal infection were included. Diagnosis of spinal 
infection was considered in patients with the following 
criteria in accordance with the international guidelines 
[11,12];  
(i) Clinical signs of spinal disease (new or 
acutely worsening chronic back pain) and  
(ii) Signs of infection (fever, high leukocyte 
count and C-reactive protein (CRP)) and  
(iii) Imaging findings suggestive of spinal 
involvement.  
 
Data collection 
Patient demographics including background 
medical history (diabetes mellitus (DM), liver disease, 
spinal trauma, previous neurosurgery), risk factors 
(presence of pneumonia, meningitis or other 
infections), and clinical data including disease onset, 
presenting symptoms and neurological examination 
findings were extracted from the medical records. In 
addition, radiological findings, localization and extent 
of spinal involvement, management and clinical 
outcome one year after the presentation were recorded. 
Patient samples submitted for microbiology evaluation 
were identified, and detailed microbiological data were 
retrieved from the laboratory database. 
 
Statistical Analysis 
Descriptive statistics were performed to examine 
the demographics and clinical parameters. Categorical 
variables were summarized by frequencies and 
percentages, and continuous data were presented as 
counts or percentages (%). We compared groups using 
the Kruskal-Wallis test for continuous variables and 
Chi-square test for categorical variables. To understand 
the risk factors associated with adverse outcome, we 
compared patients who recovered without or with 
minimal neurological sequelae with those who either 
died or recovered with significant neurological 
sequelae. All analyses were performed using SPSS 
(version 19.0). 
 
Results 
Demographic characteristics and clinical presentation 
We reviewed 28 consecutive patients who were 
admitted to the ICU with a possible diagnosis of spinal 
infection. Of those, the majority (20/28; 71%) were 
male. The mean age was 57.4 years (range 27-79), and 
20 patients (71%) were over the age of 50. At least one 
underlying risk factor was identified in 19 patients 
(68%). The most common comorbidity was DM; ten 
patients (38%) had a background history of DM, nine 
Table 1. Demographics, clinical characteristics and clinical 
outcome. 
Variable 
N (%) 
(n = 28) 
Age (years) 54.7 (27 – 79) 
> 50 years of age 20 (71) 
Sex  
Female 8 (29) 
Male 20 (71) 
Risk factors (at least one) 19 (68) 
Diabetes Mellitus 10 (38) 
Spinal trauma 3 (11) 
IVDU 2 (7) 
Chronic liver disease 2 (7) 
Neurosurgery 2 (7) 
Clinical presentation  
Fever 28 (100) 
Urinary retention 24 (86) 
Back pain 22 (79) 
Nausea 22 (79) 
Unconsciousness 7 (25) 
Headache 5 (18) 
Acute onset 18 (64) 
Positive blood culture 20 (71) 
Staphylococcus aureus 19 (95) 
Alpha hemolytic Streptococcus 1 (5) 
CSF examination (n = 25)  
Staphylococcus aureus 9 (36) 
MRI Findings  
Epidural empyema 20 (71) 
Lumbar 16 (80) 
Cervical 5 (20) 
Spondylodiscitis 13 (65) 
Spondylitis 11 (39) 
Pre-diagnosis antibiotics 13 (65) 
Outcome  
Complete recovery 7 (25) 
Recovered with neurological sequalae 12 (43) 
Died 6 (21.4) 
Neurosurgery required 7 (25) 
Recovered after neurosurgery 3/7 (49) 
IVDU: intravenous drug user; CSF: cerebrospinal fluid; MRI: magnetic 
resonance imaging. 
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of those with insulin dependence. Other accompanying 
health issues seen in patients were pneumonia (n = 7), 
urinary tract infection (n = 7), Clostridium difficile 
enterocolitis (n = 6) and meningitis (n = 2). 
All patients have presented with fever, 
predominantly accompanied by a neurological deficit 
(24/28; 86%), back pain (22/28; 79%) and nausea 
(22/28; 79%). Out of all, 18 (64%) patients had acute 
onset disease with an average nine days’ duration of 
back pain (range = 0-33 days). With regards to 
neurological symptoms, 24 (86%) patients had urinary 
retention, 15 had paraparesis (54%), 5 patients had a 
headache, and 7 patients were unconscious at the time 
of admission to the ICU. Demographics, clinical 
presentation, imaging findings and outcomes are 
summarised in Table 1.  
 
Microbiology findings 
Out of all, 20 (71%) patients had positive blood 
culture; Staphylococcus aureus (S. aureus) was isolated 
from 19 patients (95%) (all were fully susceptible 
isolates), and alpha haemolytic Streptococcus was 
isolated from one patient. Twenty-five patients 
underwent lumbar puncture. The mean cerebrospinal 
fluid (CSF) white cell count (WCC) was 1063 (0-4200) 
cells per mm3 predominantly displaying polymorphic 
picture (72% polymorphs, 24% lymphocytes), and 3 
patients had less than 5 WCC in the CSF. The mean 
parameters of CSF were as follows; glucose 3 mmol/L 
(0-10), protein 10 mmol/L (1-44) and CRP 5 mg/L (1-
15). CSF culture was positive in 36% (9/25) of patients 
with S. aureus isolated from all samples. 
 
Imaging studies 
The initial MRI findings were abnormal in all 
patients, while the CT scan showed abnormality only in 
46.7% of patients. Based on MRI findings, 20 (71%) 
patients had epidural empyema, 16 of those were 
located in the lumbar spine. Thirteen patients had 
imaging suggestive of spondylodiscitis, all of which 
were accompanied by epidural empyema. Eleven 
patients had radiological evidence of spondylitis, and 2 
patients had subdural empyema. All patients had 
follow-up MRI 6-8 weeks after the initial imaging. 
Although 10 patients (38%) had persistent changes on 
the MRI scan, 50% of those recovered without 
neurological sequelae.  
 
Antimicrobial management 
Thirteen patients had antibiotics before the 
diagnosis of spinal infection; the majority had received 
gentamicin (n = 9) and Ceftriaxone (n = 8). The mean 
time from hospital admission to initiation of antibiotic 
therapy was 12 days (range 2-34 days), and the 
meantime from neurological symptoms to the initiation 
of antibiotics was 8 days (range 2-15 days). Throughout 
the ICU admission, the average number of 
antimicrobials prescribed to one patient was 5 (3-10). 
 
Follow-up and outcome 
One-year follow up was available for all patients. A 
complete recovery was achieved in 25%(7/28). 
However, the majority (21/28) patients had adverse 
outcomes. Out of 21, 8 recovered with neurological 
sequelae, 87.5% of those with paraparesis. Six patients 
(21.4%) died, all with S. aureus bacteraemia at the time 
of PSI. Seven patients required neurosurgery, with 3 
patients achieving almost complete recovery afterwards 
with minimal neurological sequelae and the remaining 
had remaining neurological sequela. In univariate 
analyses, increased age and the presence of DM were 
identified as being associated with poor clinical 
outcome. The median age difference between those 
who completely recovered and those with poor outcome 
was 16.0 (95.0% CI 5.5, 30.0) (p = 0.003) with a cut-
off of 65 years of age as shown in Figure 1. In addition, 
the presence of pre-existing diabetes mellitus was 
associated with poor clinical outcome (p = 0.04). There 
was no association between outcome and time to 
Figure 1. Relationship between age at the time of presentation 
and outcome. 
The median age difference between those who recovered and those with 
poor outcome is shown in the above Gardner-Altman estimation plot. 
Both groups are plotted on the left axes; the mean difference is plotted 
on floating axes on the right as a bootstrap sampling distribution. The 
mean difference is depicted as a dot; the 95% confidence interval is 
indicated by the ends of the vertical error bar. The unpaired median 
difference is 16.0 (95.0% CI 5.5, 30.0). The two-sided P value of the 
Kruskal test is 0.00317.  
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antibiotics from admission, time to antibiotics from 
neurological symptoms, receipt of prior antimicrobials, 
number of antibiotics received or other laboratory 
parameters.  
 
Discussion 
The management of PSI remains a controversial 
and challenging subject. The current study highlights 
that in real-life clinical practice, PSI is still associated 
with significant morbidity and mortality. According to 
earlier studies providing long-term follow-up, the 
average mortality associated with PSI was 10-15% 
[7,2,5]. In the current study, the average mortality 
observed in ICU patients with PSI was higher (20%) 
than reported in the literature. Additionally, the residual 
neurological deficit was common, one-third of patients 
had remaining neurological sequelae, and only one-
fourth had complete recovery. 
This cohort solely included patients who were 
admitted to the ICU. Consistent with this, the majority 
of patients in this cohort had a neurological deficit at 
the time of presentation to ICU, reflecting the severity 
of their illness. In this subset of patients managed in 
ICU, increased age was shown to be a significant risk 
factor for poor clinical outcome. However, there is 
contradictory evidence about age as a prognostic factor. 
The post-hoc analysis of the Duration of Treatment for 
Spondylodiscitis (DTS) study examining 351 patients 
showed higher rates of severe adverse events in the ≥ 
75-year-old group (45.9% vs 23.3%, p < 0.001) 
regardless of the severity of neurological complications 
or time to treatment initiation [14]. In this study, older 
patients were more likely to have neoplasia and chronic 
inflammatory diseases. In a retrospective observational 
study of 7118 patients in Japan, increased age was 
associated with a risk of in-hospital mortality [15] This 
increased risk was associated with co-infection with 
infective endocarditis. Another large multicentre study 
of 253 patients with a 6.5 year follow-up did not find 
any differences in terms of clinical outcome comparing 
patients under or over 50 years [5]. Our data add to the 
available literature and indicates that patients over the 
age of 65 are at higher risk of poor clinical outcome; 
higher mortality and neurological complications. 
In our cohort, there was no association between 
clinical outcome and time to antibiotics from 
admission, time to antibiotics from neurological 
symptoms, receipt of prior antimicrobials or 
neurological impairment at presentation. In a study of 
91 patients, DM, delayed diagnosis, neurological 
impairment at diagnosis and spinal cord or cauda equina 
compression were found as strong predictors of poor 
treatment outcome [16]. The presence of DM, end-stage 
renal disease and cirrhosis have also been shown to be 
associated with adverse clinical outcomes [,16,17,18]. 
This highlights that unfavourable outcome may also be 
driven by patient-related factors as well as the severity 
of clinical presentation. 
In this study, the presence of pre-existing DM was 
associated with an unfavourable outcome. DM is one of 
the major global health threats of the 21st century; it is 
estimated that by 2045 there will be 693 million persons 
living with DM [19]. From infectious diseases 
perspective this is concerning as DM increases the 
susceptibility to all infections, especially to bone and 
joint infections [20], and the current study suggests that 
it may also influence the treatment outcomes in PSI. 
This highlights the importance of including DM as an 
important independent variable for future PSI studies to 
further understand the association between DM control 
and management of DM-associated complications and 
PSI incidence as well as treatment outcomes.  
The infection in PSI is generally mono-microbial, 
with S. aureus being the leading causative agent 
accounting for half of the cases [21,1]. Most cases of 
PSI follow a haematogenous spread but also could 
follow direct inoculation following surgery or epidural 
procedures, and although rare could be caused by 
contiguous spread from a nearby infective focus [22]. 
The paraspinal or epidural extension is the most 
frequently reported complications. In this cohort, S. 
aureus was the most commonly isolated organism from 
the blood culture. CT imaging was abnormal in only 
half of the patients, whereas simultaneous MRI imaging 
suggested abnormal findings in all patients. The 
common finding seen in MRI was epidural empyema 
with predominantly lumbar spine involvement. In a 
recent study examining the spinal involvement in PSI, 
multifocal involvement was found to be common (35%) 
[23]. This highlights the need to image the entire spine, 
especially prior to any surgical intervention. In our 
cohort, the majority of patients had persistent MRI 
abnormalities 6-8 weeks after the initial imaging, 
despite half of them recovering without sequelae. This 
emphasises that imaging could be performed 
infrequently during the treatment of PSI, as it may not 
directly inform patient management.  
The significance of the present study is that we 
provide 5-years of real-life clinical experience of 
managing PSI in an ICU setting. On the other hand, 
there are some limitations. Due to its retrospective 
nature, some relevant information might have been 
missed during data collection. Although our case series 
is unique to incorporate clinical, microbiological and 
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treatment information, sample size remains limited. In 
addition, although 95% of patients with positive blood 
culture had S. aureus bacteraemia, none of the patients 
had a CT guided biopsy. Previous studies suggest that 
initial biopsy is only positive in minority of the cases 
and has an even lower yield in patients with prior 
antibiotic exposure [24]. Contrary, a few other studies 
shown that the majority of bone biopsies yield S. aureus 
[22,13]. Therefore, the role of bone biopsy is still 
debated, especially if the blood culture is positive. In a 
recent study, diagnosis of PSI with histology has been 
shown to have better sensitivity compared to 
microbiology [25], which may be helpful in patients 
with negative blood culture.  
 
Conclusion 
This paper provides valuable information on the 
management of this challenging condition utilising the 
real-life clinical data. In patients admitted to ICU with 
PSI accompanied by neurological deficit, the average 
mortality observed was higher (20%) than reported in 
the literature. Additionally, residual neurological deficit 
was common, one-third of patients had remaining 
neurological sequelae and only one-fourth had 
complete recovery. Increased age and background DM 
were the most important determinants of poor clinical 
outcome in PSI. The impact of DM appears to be much 
more important than currently recognised in this 
population. The impact of DM management on PSI 
incidence and treatment outcomes should be explored 
further in this population. 
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